Ghost Tree Capital’s Avadel Pharmaceuticals AVDL Stock Holding History

Ghost Tree Capital’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-825,000	Closed	-$4.16M	–	49
2020 Q3	$4.16M	Hold	825,000	–	–	1.2%	27
2020 Q2	$6.67M	Buy	825,000 +475,000	+136%	+$4.19M	1.76%	23
2020 Q1	$2.78M	Buy	+350,000	New	+$2.69M	0.74%	29
2018 Q4	–	Sell	-450,000	Closed	-$1.98M	–	47
2018 Q3	$1.98M	Hold	450,000	–	–	0.42%	45
2018 Q2	$2.76M	Sell	450,000 -400,000	-47%	-$2.81M	0.81%	35
2018 Q1	$6.2M	Buy	+850,000	New	+$7.48M	1.25%	26
2017 Q1	–	Sell	-575,000	Closed	-$5.97M	–	70
2016 Q4	$5.97M	Hold	575,000	–	–	1.44%	30
2016 Q3	$7.13M	Buy	575,000 +225,000	+64%	+$2.94M	1.16%	31
2016 Q2	$3.76M	Buy	+350,000	New	+$3.73M	1.09%	38
2015 Q4	–	Sell	-350,000	Closed	-$5.71M	–	52
2015 Q3	$5.71M	Sell	350,000 -225,000	-39%	-$4.96M	2.57%	12
2015 Q2	$12.2M	Buy	575,000 +375,000	+188%	+$6.72M	3.95%	2
2015 Q1	$3.6M	Sell	200,000 -125,000	-38%	-$1.96M	1.29%	38
2014 Q4	$5.57M	Buy	+325,000	New	+$4.64M	2.67%	9
2014 Q3	–	Sell	-75,000	Closed	-$1.13M	–	73
2014 Q2	$1.13M	Sell	75,000 -225,000	-75%	-$2.71M	0.79%	38
2014 Q1	$4.02M	Buy	300,000 +180,000	+150%	+$1.93M	2.39%	11
2013 Q4	$966K	Buy	+120,000	New	+$847K	0.59%	50

Other funds holding AVDL

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

GJL

Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ACM

Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Ghost Tree Capital's AVDL Position: Q4 2020 in Review

Ghost Tree Capital sold out of Avadel Pharmaceuticals (AVDL) in Q4 2020, closing a stake of 825,000 shares — an estimated $4.16M sold.

Ghost Tree Capital first reported a position in AVDL in Q4 2013 and held it in 16 quarters. The position peaked at $12.2M in Q2 2015. 82 funds tracked by Wall St. Rank hold AVDL as of Q4 2020.

Ghost Tree Capital reported no remaining Avadel Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Ghost Tree Capital sold 825,000 Avadel Pharmaceuticals shares in Q4 2020, an estimated $4.16M.
Ghost Tree Capital first reported a position in Avadel Pharmaceuticals in Q4 2013 and held it in 16 quarters.
Ghost Tree Capital's Avadel Pharmaceuticals position peaked at $12.2M in Q2 2015.
82 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2020.

Based on Ghost Tree Capital's 13F filing for Q4 2020, filed 16 Feb 2021.